000 01389 a2200421 4500
005 20250518061333.0
264 0 _c20210427
008 202104s 0 0 eng d
022 _a1029-2403
024 7 _a10.1080/10428194.2019.1660975
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aManur, Rashmi
245 0 0 _aLeukemic lineage switch in a t(8;22)(p11.2;q11.2)/
_h[electronic resource]
260 _bLeukemia & lymphoma
_c02 2020
300 _a450-454 p.
_bdigital
500 _aPublication Type: Case Reports; Letter
650 0 4 _aCore Binding Factor Alpha 2 Subunit
_xgenetics
650 0 4 _aGene Rearrangement
650 0 4 _aHumans
650 0 4 _aLeukemia, Myeloid
_xdrug therapy
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aMorpholines
_xtherapeutic use
650 0 4 _aMutation
650 0 4 _aPyrimidines
_xtherapeutic use
650 0 4 _aPyrroles
_xtherapeutic use
650 0 4 _aReceptor, Fibroblast Growth Factor, Type 1
_xgenetics
650 0 4 _aTranslocation, Genetic
700 1 _aSung, Pamela J
700 1 _aLoren, Alison W
700 1 _aRitchie, Ellen K
700 1 _aFrank, Dale
700 1 _aBagg, Adam
700 1 _aGeyer, Julia T
700 1 _aBogusz, Agata M
773 0 _tLeukemia & lymphoma
_gvol. 61
_gno. 2
_gp. 450-454
856 4 0 _uhttps://doi.org/10.1080/10428194.2019.1660975
_zAvailable from publisher's website
999 _c30114968
_d30114968